vimarsana.com
Home
Live Updates
Vaccines announce european partnership for marketing
Live Breaking News & Updates on Vaccines announce european partnership for marketing
VALNEVA: Valneva Reports Full Year 2022 Results and Provides Corporate Updates
Total revenues of €361.3 million in 2022 compared to €348.1 million in 2021 Driven by product sales of €114.8 million (82.3% increase compared to 2021), including €85.2 million of travel vaccine sales
Japan
,
Finland
,
Australia
,
Thailand
,
France
,
New-zealand
,
Sweden
,
United-kingdom
,
United-arab-emirates
,
Denmark
,
Austria
,
Germany